FDA Clearance Tracker · P100047-S139
HeartWare HVAD System
Last checked: Nov 20, 2026Latest source record: Oct 21, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Oct 21, 2019
Approved
Time to decision
179 days
Received Apr 25, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P100047-S139
- Device name
- HeartWare HVAD System
- Applicant
- Medtronic
- Applicant location
- Mounds View, MN
- Received
- Apr 25, 2019
- Decided
- Oct 21, 2019
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P100047
Device type
- Device type
- Ventricular (assist) bypass (DSQ)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for revisions to the Instructions for Use to include findings from the Bridge-to-Transplant PAS03 study and data from longer term follow-up of ENDURANCE Supplemental study subjects.
Source documents
Other decisions for Medtronic
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262716 · Decided Nov 6, 2026 · 98 days after receipt
Device type: Neurological Stereotaxic Instrument (HAW) · Neurology & Neurosurgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.